• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
GBI
Click for more information
0.00% 0.0¢

GENERA BIOSYSTEMS LIMITED - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
GBI Change of Director's Interest Notice23/12/16
GBI Appendix 3B23/12/16
GBI Proposed Amendments to Existing Series B Convertible NotesPRICE SENSITIVE13/12/16
GBI Results of Annual General Meeting24/11/16
GBI 2016 CEO AGM Presentation24/11/16
GBI Genera Receives R&D Tax RebatePRICE SENSITIVE21/11/16
GBI Genera anticipates to receive $752k R&D rebatePRICE SENSITIVE15/11/16
GBI Appendix 3B11/11/16
GBI Genera Lodges Application for PapType Medicare BenefitsPRICE SENSITIVE11/11/16
GBI Appendix 3B09/11/16
GBI Change of Director's Interest Notice04/11/16
GBI Business Update and September 2016 Appendix 4C-GBI.AX PRICE SENSITIVE01/11/16
GBI September 2016 Appendix 4C-GBI.AX PRICE SENSITIVE01/11/16
GBI Change in substantial holding-GBI.AX 24/10/16
GBI Notice of Annual General Meeting/Proxy Form-GBI.AX 21/10/16
GBI Data from US based Screening population-GBI.AX PRICE SENSITIVE03/10/16
GBI Annual Report Highlights-GBI.AX 03/10/16
GBI 2016 Annual Report to Shareholders (Amended)-GBI.AX 03/10/16
GBI Appendix 4G and Corporate Governance Statement-GBI.AX 30/09/16
GBI 2016 Annual Report to Shareholders-GBI.AX 30/09/16
GBI 30 June 2016 Appendix 4E - Preliminary Final Report-GBI.AX PRICE SENSITIVE31/08/16
GBI Business Update and June 2016 Appendix 4C-GBI.AX PRICE SENSITIVE29/07/16
GBI Indian Market Update and Regulatory Approval-GBI.AX PRICE SENSITIVE21/06/16
GBI Change of Director's Interest Notice-GBI.AX 06/05/16
GBI Change of Director's Interest Notice-GBI.AX 02/05/16
GBI Business Update and March 2016 Appendix 4C-GBI.AX PRICE SENSITIVE28/04/16
GBI Change of Director's Interest Notice-GBI.AX 08/04/16
GBI Appendix 3B and Section 708A Cleansing Statement-GBI.AX 08/04/16
GBI Change of Director's Interest Notice11/03/16
GBI Change in substantial holding03/03/16
GBI Appendix 4D and Half Year Financial ReportPRICE SENSITIVE29/02/16
GBI Business Update and December 2015 Appendix 4CPRICE SENSITIVE29/01/16
GBI Change of Director's Interest Notice29/12/15
GBI Appendix 3B and Section 708A Cleansing Statement29/12/15
GBI Change of Director's Interest Notice24/12/15
GBI Results of Meeting26/11/15
GBI 2015 AGM Presentation26/11/15
GBI Change of Director's Interest Notice03/11/15
GBI Business Update and September 2015 Appendix 4CPRICE SENSITIVE30/10/15
GBI Change of Director's Interest Notice29/10/15
GBI Notice of Annual General Meeting/Proxy Form26/10/15
GBI World Class Clinical & Scientific Advisory Board Established23/10/15
GBI Change of Director's Interest Notice21/10/15
GBI Change of Director's Interest Notice13/10/15
GBI Appendix 4G and Corporate Governance Statement30/09/15
GBI 2015 Annual Report30/09/15
GBI 2015 Annual Report Highlights30/09/15
GBI Appendix 3B and Section 708A Cleansing Statement07/09/15
GBI 2015 Appendix 4E - Preliminary final reportPRICE SENSITIVE31/08/15
GBI Appendix 3B and Section 708A Cleansing Statement07/08/15
GBI Genera Receives 6,000 Patient Study Clinical DataPRICE SENSITIVE07/08/15
GBI Business Update and June 2015 Appendix 4CPRICE SENSITIVE31/07/15
GBI Indian market launch of AmpaSand assaysPRICE SENSITIVE17/07/15
GBI Ceasing and Initial Substantial Shareholder Notices06/07/15
GBI Appendix 3B and Section 708A Cleansing Statement20/05/15
GBI Business Update and March 2015 Appendix 4CPRICE SENSITIVE30/04/15
GBI Appendix 3B and Section 708A Cleansing Statement13/04/15
GBI Change of Director's Interest Notices x 409/04/15
GBI CE MARK of PapType and RTI-plex MDx ASSAYSPRICE SENSITIVE08/04/15
GBI Appendix 3B11/03/15
GBI ARTG ListingsPRICE SENSITIVE11/03/15
GBI TGA Issues Conformity Assessment CertificatePRICE SENSITIVE05/03/15
GBI Change in substantial holding03/03/15
GBI Placement of Final Tranche of Unlisted Convertible NotesPRICE SENSITIVE02/03/15
GBI Appendix 4D and Half Year Financial ReportPRICE SENSITIVE27/02/15
GBI Appendix 3B09/02/15
GBI Appendix 4C - quarterlyPRICE SENSITIVE30/01/15
GBI Appendix 3B and Section 708A Cleansing Statement31/12/14
GBI Reinstatement to Official QuotationPRICE SENSITIVE19/12/14
GBI Placement of Unlisted Convertible NotesPRICE SENSITIVE19/12/14
GBI Extension of Voluntary Suspension18/12/14
GBI Suspension from Official QuotationPRICE SENSITIVE12/12/14
GBI Trading HaltPRICE SENSITIVE10/12/14
GBI Response to Appendix 4C QueryPRICE SENSITIVE01/12/14
GBI Results of Meeting28/11/14
GBI 2014 AGM Presentation28/11/14
GBI Change of Director's Interest Notice21/11/14
GBI Change of Director's Interest Notices x 411/11/14
GBI Appendix 3B11/11/14
GBI Appendix 4C - quarterlyPRICE SENSITIVE31/10/14
GBI Change of Director's Interest Notice29/10/14
GBI Annual Report to shareholders28/10/14
GBI Notice of Annual General Meeting/Proxy Form28/10/14
GBI Terms of CEO Employment Services Agreement23/10/14
GBI Change of Director's Interest Notices x 410/10/14
GBI Appendix 3B10/10/14
GBI Beckman Coulter SCC and CEO AppointmentPRICE SENSITIVE02/10/14
GBI Change of Director's Interest Notices x 415/09/14
GBI Appendix 3B15/09/14
GBI Genera Lodges TGA ApplicationPRICE SENSITIVE03/09/14
GBI 2014 Appendix 4E and Annual ReportPRICE SENSITIVE01/09/14
GBI Strategic Commercial AlliancePRICE SENSITIVE18/08/14
GBI Change of Director's Interest Notices x 514/08/14
GBI Appendix 3B14/08/14
GBI Appendix 4C - quarterlyPRICE SENSITIVE31/07/14
GBI Change of Director's Interest Notices x 515/07/14
GBI Appendix 3B15/07/14
GBI Appendix 3B02/07/14
GBI Strategic Review OutcomePRICE SENSITIVE30/06/14
GBI Health Canada approves HPV test as Primary Screening ToolPRICE SENSITIVE16/06/14
GBI Change of Director's Interest Notice
23/12/16
GBI Appendix 3B
23/12/16
GBI Proposed Amendments to Existing Series B Convertible Notes
13/12/16PRICE SENSITIVE
GBI Results of Annual General Meeting
24/11/16
GBI 2016 CEO AGM Presentation
24/11/16
GBI Genera Receives R&D Tax Rebate
21/11/16PRICE SENSITIVE
GBI Genera anticipates to receive $752k R&D rebate
15/11/16PRICE SENSITIVE
GBI Appendix 3B
11/11/16
GBI Genera Lodges Application for PapType Medicare Benefits
11/11/16PRICE SENSITIVE
GBI Appendix 3B
09/11/16
GBI Change of Director's Interest Notice
04/11/16
GBI Business Update and September 2016 Appendix 4C-GBI.AX
01/11/16PRICE SENSITIVE
GBI September 2016 Appendix 4C-GBI.AX
01/11/16PRICE SENSITIVE
GBI Change in substantial holding-GBI.AX
24/10/16
GBI Notice of Annual General Meeting/Proxy Form-GBI.AX
21/10/16
GBI Data from US based Screening population-GBI.AX
03/10/16PRICE SENSITIVE
GBI Annual Report Highlights-GBI.AX
03/10/16
GBI 2016 Annual Report to Shareholders (Amended)-GBI.AX
03/10/16
GBI Appendix 4G and Corporate Governance Statement-GBI.AX
30/09/16
GBI 2016 Annual Report to Shareholders-GBI.AX
30/09/16
GBI 30 June 2016 Appendix 4E - Preliminary Final Report-GBI.AX
31/08/16PRICE SENSITIVE
GBI Business Update and June 2016 Appendix 4C-GBI.AX
29/07/16PRICE SENSITIVE
GBI Indian Market Update and Regulatory Approval-GBI.AX
21/06/16PRICE SENSITIVE
GBI Change of Director's Interest Notice-GBI.AX
06/05/16
GBI Change of Director's Interest Notice-GBI.AX
02/05/16
GBI Business Update and March 2016 Appendix 4C-GBI.AX
28/04/16PRICE SENSITIVE
GBI Change of Director's Interest Notice-GBI.AX
08/04/16
GBI Appendix 3B and Section 708A Cleansing Statement-GBI.AX
08/04/16
GBI Change of Director's Interest Notice
11/03/16
GBI Change in substantial holding
03/03/16
GBI Appendix 4D and Half Year Financial Report
29/02/16PRICE SENSITIVE
GBI Business Update and December 2015 Appendix 4C
29/01/16PRICE SENSITIVE
GBI Change of Director's Interest Notice
29/12/15
GBI Appendix 3B and Section 708A Cleansing Statement
29/12/15
GBI Change of Director's Interest Notice
24/12/15
GBI Results of Meeting
26/11/15
GBI 2015 AGM Presentation
26/11/15
GBI Change of Director's Interest Notice
03/11/15
GBI Business Update and September 2015 Appendix 4C
30/10/15PRICE SENSITIVE
GBI Change of Director's Interest Notice
29/10/15
GBI Notice of Annual General Meeting/Proxy Form
26/10/15
GBI World Class Clinical & Scientific Advisory Board Established
23/10/15
GBI Change of Director's Interest Notice
21/10/15
GBI Change of Director's Interest Notice
13/10/15
GBI Appendix 4G and Corporate Governance Statement
30/09/15
GBI 2015 Annual Report
30/09/15
GBI 2015 Annual Report Highlights
30/09/15
GBI Appendix 3B and Section 708A Cleansing Statement
07/09/15
GBI 2015 Appendix 4E - Preliminary final report
31/08/15PRICE SENSITIVE
GBI Appendix 3B and Section 708A Cleansing Statement
07/08/15
GBI Genera Receives 6,000 Patient Study Clinical Data
07/08/15PRICE SENSITIVE
GBI Business Update and June 2015 Appendix 4C
31/07/15PRICE SENSITIVE
GBI Indian market launch of AmpaSand assays
17/07/15PRICE SENSITIVE
GBI Ceasing and Initial Substantial Shareholder Notices
06/07/15
GBI Appendix 3B and Section 708A Cleansing Statement
20/05/15
GBI Business Update and March 2015 Appendix 4C
30/04/15PRICE SENSITIVE
GBI Appendix 3B and Section 708A Cleansing Statement
13/04/15
GBI Change of Director's Interest Notices x 4
09/04/15
GBI CE MARK of PapType and RTI-plex MDx ASSAYS
08/04/15PRICE SENSITIVE
GBI Appendix 3B
11/03/15
GBI ARTG Listings
11/03/15PRICE SENSITIVE
GBI TGA Issues Conformity Assessment Certificate
05/03/15PRICE SENSITIVE
GBI Change in substantial holding
03/03/15
GBI Placement of Final Tranche of Unlisted Convertible Notes
02/03/15PRICE SENSITIVE
GBI Appendix 4D and Half Year Financial Report
27/02/15PRICE SENSITIVE
GBI Appendix 3B
09/02/15
GBI Appendix 4C - quarterly
30/01/15PRICE SENSITIVE
GBI Appendix 3B and Section 708A Cleansing Statement
31/12/14
GBI Reinstatement to Official Quotation
19/12/14PRICE SENSITIVE
GBI Placement of Unlisted Convertible Notes
19/12/14PRICE SENSITIVE
GBI Extension of Voluntary Suspension
18/12/14
GBI Suspension from Official Quotation
12/12/14PRICE SENSITIVE
GBI Trading Halt
10/12/14PRICE SENSITIVE
GBI Response to Appendix 4C Query
01/12/14PRICE SENSITIVE
GBI Results of Meeting
28/11/14
GBI 2014 AGM Presentation
28/11/14
GBI Change of Director's Interest Notice
21/11/14
GBI Change of Director's Interest Notices x 4
11/11/14
GBI Appendix 3B
11/11/14
GBI Appendix 4C - quarterly
31/10/14PRICE SENSITIVE
GBI Change of Director's Interest Notice
29/10/14
GBI Annual Report to shareholders
28/10/14
GBI Notice of Annual General Meeting/Proxy Form
28/10/14
GBI Terms of CEO Employment Services Agreement
23/10/14
GBI Change of Director's Interest Notices x 4
10/10/14
GBI Appendix 3B
10/10/14
GBI Beckman Coulter SCC and CEO Appointment
02/10/14PRICE SENSITIVE
GBI Change of Director's Interest Notices x 4
15/09/14
GBI Appendix 3B
15/09/14
GBI Genera Lodges TGA Application
03/09/14PRICE SENSITIVE
GBI 2014 Appendix 4E and Annual Report
01/09/14PRICE SENSITIVE
GBI Strategic Commercial Alliance
18/08/14PRICE SENSITIVE
GBI Change of Director's Interest Notices x 5
14/08/14
GBI Appendix 3B
14/08/14
GBI Appendix 4C - quarterly
31/07/14PRICE SENSITIVE
GBI Change of Director's Interest Notices x 5
15/07/14
GBI Appendix 3B
15/07/14
GBI Appendix 3B
02/07/14
GBI Strategic Review Outcome
30/06/14PRICE SENSITIVE
GBI Health Canada approves HPV test as Primary Screening Tool
16/06/14PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Tambourah chases gold veins and mineralisation extension with drilling Tambourah Metals Ltd has discovered two high-grade gold veins through a diamond drilling program in Western Australia
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.